DCF — SCHNECK MEDICAL CENTER
Enterprise Value: $-56.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-56.2M
Enterprise Value
$-23.0M
PV of Cash Flows
$-33.2M
PV of Terminal Value
$-53.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $189.8M | $-0.7M | -0.0% | $-8.7M | $-7.9M |
| Year 2 | $195.5M | $1.3M | 1.0% | $-7.0M | $-5.8M |
| Year 3 | $201.3M | $3.3M | 2.0% | $-5.2M | $-3.9M |
| Year 4 | $207.4M | $4.5M | 2.0% | $-4.3M | $-2.9M |
| Year 5 | $213.6M | $5.1M | 2.0% | $-3.9M | $-2.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-56.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$184.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.008479491175273612
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5